Video

Darolutamide shows less cognitive decline than enzalutamide in advanced prostate cancer

Tafasitamab plus lenalidomide and R-CHOP delays disease progression in aggressive B-cell lymphomas

Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard of care in triple-negative breast cancer

Neoadjuvant chemoradiotherapy plus sintilimab improves pCR in resectable locally advanced oesophageal squamous cell carcinoma

Omission of axillary lymph node dissection reduces arm morbidity without compromising survival in select breast cancer cases

ASCO 2026: Breast cancer overview

Bezuclastinib sunitinib combo shows promise in second-line GIST treatment

mRNA-4359 plus pembrolizumab shows high response rates and robust T-cell activation in melanoma

Is radiotherapy a back up plan after neoadjuvant chemo-immunotherapy in perioperative lung cancer management?

Part 1: Why test?

Part 2: How to get biopsies for testing?

Part 3: Managing testing efficiencies – How to optimise next generation sequencing and HRR testing